Physician Blog
-
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why.
Prolaris: Your NEW ADT decision tool When it comes to treating NCCN intermediate- and high-risk prostate cancer, it can be […]
-
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why.
-
Myriad Genetics is committed to being your partner of choice
-
Genetic insights for more actionable and personalized prostate cancer
-
Prolaris® is advancing prostate cancer care at ASCO GU
-
Prolaris® is Helping Urologists Reimagine Prostate Cancer Care
-
New Study Proves that Prolaris can Determine which Patients Can Safely Avoid ADT
-
New Data Validating the Prolaris® Test to Guide Treatment for Prostate Cancer
-
1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation
-
New Treatment Options Available
-
Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer
-
A Message from Myriad Regarding COVID-19
-
Once You Establish These Advanced Prostate Cancer Clinics, It's Easy to…
-
Having a Negative MRI Does Not Mean That You Don't Have a Significant Cancer.